AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 4 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $288,000 | -80.2% | 17,300 | -77.9% | 0.01% | -78.6% |
| Q1 2013 | $1,453,000 | +84.9% | 78,400 | +84.9% | 0.03% | +75.0% |
| Q4 2012 | $786,000 | -24.2% | 42,400 | 0.0% | 0.02% | -33.3% |
| Q3 2012 | $1,037,000 | -9.0% | 42,400 | 0.0% | 0.02% | -17.2% |
| Q2 2012 | $1,140,000 | +44.9% | 42,400 | 0.0% | 0.03% | +45.0% |
| Q1 2012 | $787,000 | -13.4% | 42,400 | -7.0% | 0.02% | -16.7% |
| Q4 2011 | $909,000 | – | 45,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |